Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy. Rab MAE, Bos J, van Oirschot BA, van Straaten S, et al. Blood 2021;137:2997-3001.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rab MAE, Bos J, van Oirschot BA, van Straaten S, et al. Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy. Blood 2021;137:2997-3001.
PMID: 33690814